Sign in
Home
CEO Interviews
Webinar Schedules
Webinar Replays
News
Schedule Interview
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
CEORoadshow Interviews
CEORoadshow Interviews Gary Campbell, CEO of Cytta Corp. (OTCQB: CYCA)
CEORoadshow Interviews
CEORoadshow Interviews Brian Goodman, CEO of Golden Matrix Group (NASDAQ: GMGI)
CEORoadshow Interviews
CEORoadshow Interviews Lior Tal, CEO of Cyngn, Inc. (NASDAQ: CYN)
CEORoadshow Interviews
CEORoadshow Interviews Scott Absher, CEO of ShiftPixy, Inc. (NASDAQ: PIXY)
CEORoadshow Interviews
CEORoadshow Interviews Sincerity Applied Materials Holding (SINC) CEO James Zhang
CEO Interviews
CEORoadshow Interviews
CEORoadshow Interviews Gary Campbell, CEO of Cytta Corp. (OTCQB: CYCA)
CEORoadshow Interviews
CEORoadshow Interviews Brian Goodman, CEO of Golden Matrix Group (NASDAQ: GMGI)
CEORoadshow Interviews
CEORoadshow Interviews Lior Tal, CEO of Cyngn, Inc. (NASDAQ: CYN)
CEORoadshow Interviews
CEORoadshow Interviews Scott Absher, CEO of ShiftPixy, Inc. (NASDAQ: PIXY)
CEORoadshow Interviews
CEORoadshow Interviews Sincerity Applied Materials Holding (SINC) CEO James Zhang
Webinar Schedules
Webinars
CEORoadshow 2022 Webinar Series Presents Inspira Technologies (Nasdaq: IINN)
Webinars
CEORoadshow 2023 Webinar Series Presents Cyngn, Inc. (NASDAQ: CYN)
Webinars
CEORoadshow 2022 Webinar Series Presents Quad M Solutions, Inc. (Ticker: MMMM)
News
CEORoadshow 2022 Webinar Series Presents A2Z Smart Technologies, Inc. (NASDAQ:AZ)
Webinars
CEORoadshow Presents Usio, Inc. (NASDAQ: USIO)
Webinar Replays
News
Schedule Interview
Contact Us
CEORoadShow
AIM ImmunoTech Articles
AIM ImmunoTech News
AIM ImmunoTech Videos
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AIM ImmunoTech Announces Further Efforts to Establish Clinical Trials Assessing Ampligen as a Potential Protective and Early-Onset Treatment for...
CEO Roadshow
-
March 26, 2020
0
AIM ImmunoTech Provides Comprehensive Clinical Trials Update With Major Inflection Points Identified
CEO Roadshow
-
October 7, 2019
0
Hemispherx Biopharma, Inc. Changes Name to AIM ImmunoTech Inc. Reflecting Ampligen’s® Immuno Modulation Progress in Ongoing Oncology Clinical Trials...
CEO Roadshow
-
August 23, 2019
0
AIM ImmunoTech News
Home
AIM ImmunoTech
AIM ImmunoTech News
AIM ImmunoTech News
Hemispherx Reports Positive Safety and Survival Data in Phase 1 Stage...
CEO Roadshow
-
August 8, 2019
0
AIM ImmunoTech News
Hemispherx Secures Corrections from Two Stock News Organizations Related to Their...
CEO Roadshow
-
August 2, 2019
0
AIM ImmunoTech News
Hemispherx Biopharma (NYSE:HEB) Initiated at Maxim with Buy and $8 Target
CEO Roadshow
-
June 14, 2019
0
AIM ImmunoTech News
Hemispherx Biopharma Announces Significant Progress in its Ampligen Ovarian Cancer Program
CEO Roadshow
-
May 1, 2019
0
AIM ImmunoTech News
Hemispherx Biopharma Announces Significant Progress in its Ampligen Pancreatic Cancer Program...
CEO Roadshow
-
March 13, 2019
0
AIM ImmunoTech News
Hemispherx Biopharma Updates the Terms of Previously Announced Rights Offering and...
CEO Roadshow
-
February 27, 2019
0
AIM ImmunoTech News
Hemispherx Biopharma Announces Commencement of a New 45 Subject Clinical Trial...
CEO Roadshow
-
February 11, 2019
0
AIM ImmunoTech News
Hemispherx Biopharma Announces Key Dates and Timeline for Stockholder Participation in...
CEO Roadshow
-
February 6, 2019
0
AIM ImmunoTech News
Hemispherx Biopharma Announces IRB Approval of Clinical Study in Metastatic Triple...
CEO Roadshow
-
January 8, 2019
0
AIM ImmunoTech News
Hemispherx Biopharma Inc. Announces Advancement in Expanded Access Program for Ampligen...
CEO Roadshow
-
January 2, 2019
0
1
2
Page 1 of 2
- Advertisement -
LATEST NEWS
Cytta’s First Responder Clients Conduct Advanced IGAN Training Exercises in Texas and California
CEO Roadshow
-
January 31, 2023
Panacea Announces Letter of Intent to Acquire N7 Enterprises, Inc.
CEO Roadshow
-
January 23, 2023
Usio to Ring Nasdaq Closing Bell November 23
CEO Roadshow
-
November 17, 2022
Usio Announces Third Quarter 2022 Financial Results
CEO Roadshow
-
November 9, 2022
LATEST INTERVIEWS
CEORoadshow Interviews Gary Campbell, CEO of Cytta Corp. (OTCQB: CYCA)
CEO Roadshow
-
December 21, 2022
0
CEORoadshow Interviews
In this CEO interview we are joined by Mr. Gary Campbell, CEO of Cytta Corp. Cytta develops and distributes proprietary software technology to shift how...
CEORoadshow Interviews Brian Goodman, CEO of Golden Matrix Group (NASDAQ:...
CEO Roadshow
-
December 21, 2022
0
CEORoadshow Interviews
In this CEO interview we are joined by Mr. Brian Goodman, CEO of Golden Matrix Group. Their stock trades on the NASDAQ under ticker GMGI. Contact...
